FDA Approved: CRYSVITA — Supplemental Application (Kyowa Kirin, Inc.)

View source ↗

Summary

FDA approved a supplemental application for CRYSVITA (burosumab) submitted by Kyowa Kirin, Inc. to update the product labeling. The document concerns changes to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• X-linked Hypophosphatemia

Drugs mentioned

• Crysvita (burosumab)

Snippet

SUPPL AP for CRYSVITA (BUROSUMAB)